ConvaTec Group PLC
LSE:CTEC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China Ouhua Winery Holdings Ltd
KLSE:CNOUHUA
|
CN |
ConvaTec Group PLC
Cash from Operating Activities
ConvaTec Group PLC
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
ConvaTec Group PLC
LSE:CTEC
|
Cash from Operating Activities
$470m
|
CAGR 3-Years
19%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Abingdon Health PLC
LSE:ABDX
|
Cash from Operating Activities
-£3.2m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Tristel PLC
LSE:TSTL
|
Cash from Operating Activities
£10.5m
|
CAGR 3-Years
20%
|
CAGR 5-Years
6%
|
CAGR 10-Years
11%
|
|
|
Inspecs Group PLC
LSE:SPEC
|
Cash from Operating Activities
£7.2m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Advanced Medical Solutions Group PLC
LSE:AMS
|
Cash from Operating Activities
£32.6m
|
CAGR 3-Years
7%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
|
Rua Life Sciences PLC
LSE:RUA
|
Cash from Operating Activities
-£193k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ConvaTec Group PLC
Glance View
ConvaTec Group PLC is a notable player in the realm of medical products and technologies, deftly weaving its narrative within the healthcare industry. Founded in 1978, the company has steadily established itself through strategic expansion and innovation, focusing on improving the lives of patients and enhancing healthcare delivery. The company's core business revolves around four main product categories: Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Each of these sectors is backed by a robust commitment to research and development, allowing ConvaTec to deliver specialized products that cater to both specific patient needs and broader healthcare system demands. ConvaTec's financial model centers around providing essential, high-quality medical solutions that ultimately support improved patient outcomes. The company garners revenue by partnering with hospitals, healthcare providers, and direct consumer channels, ensuring its products reach where they are most needed. With a global footprint spanning multiple continents, ConvaTec not only distributes its products widely but also adapts its strategy to meet the nuanced requirements of diverse markets. By aligning itself closely with caregivers and leveraging cutting-edge technology, the company maintains a sustainable economic engine through both recurring sales from consumables and long-term relationships with its institutional clients.
See Also
What is ConvaTec Group PLC's Cash from Operating Activities?
Cash from Operating Activities
470m
USD
Based on the financial report for Dec 31, 2025, ConvaTec Group PLC's Cash from Operating Activities amounts to 470m USD.
What is ConvaTec Group PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
3%
Over the last year, the Cash from Operating Activities growth was 19%. The average annual Cash from Operating Activities growth rates for ConvaTec Group PLC have been 19% over the past three years , 3% over the past five years .